208 related articles for article (PubMed ID: 17565339)
1. Bisphosphonates: are they standard of care for the treatment of breast cancer?
Pritchard KI
Br J Cancer; 2007 Jun; 96(12):1781-2. PubMed ID: 17565339
[No Abstract] [Full Text] [Related]
2. Bisphosphonates in early breast cancer.
Dubsky P; Bartsch R
Lancet Oncol; 2012 Jul; 13(7):660-1. PubMed ID: 22704582
[No Abstract] [Full Text] [Related]
3. Bisphosphonates and other bone agents for breast cancer.
O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
[TBL] [Abstract][Full Text] [Related]
4. [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
Caffo O
Tumori; 2005; 91(5):22-6. PubMed ID: 16459649
[No Abstract] [Full Text] [Related]
5. [Bisphosphonates in adjuvant therapy of breast cancer].
Deuber HJ; Theiss F
Med Klin (Munich); 2010 Sep; 105(9):635-46. PubMed ID: 20878301
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates and tumor burden.
Mundy GR
J Clin Oncol; 2002 Aug; 20(15):3191-2. PubMed ID: 12149289
[No Abstract] [Full Text] [Related]
7. Bisphosphonates as adjuvant treatment for breast cancer.
Gralow JR
BMJ; 2002 Nov; 325(7372):1051-2. PubMed ID: 12424151
[No Abstract] [Full Text] [Related]
8. Meta-analysis of clodronate and breast cancer survival.
Ha TC; Li H
Br J Cancer; 2007 Jun; 96(12):1796-801. PubMed ID: 17325699
[TBL] [Abstract][Full Text] [Related]
9. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Major PP; Lipton A; Berenson J; Hortobagyi G
Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?
Amoroso V; Petrelli F; Pedersini R; Simoncini EL; Clézardin P; Barni S; Berruti A
Future Oncol; 2015; 11(21):2853-6. PubMed ID: 26403833
[No Abstract] [Full Text] [Related]
11. Clodronate in the prevention and treatment of skeletal metastasis.
Gulley J; Dahut WL
Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of bisphosphonates for bone metastasis in breast cancer].
Yamada K; Kohno N
Nihon Rinsho; 2007 Nov; 65 Suppl 9():352-5. PubMed ID: 18161130
[No Abstract] [Full Text] [Related]
13. Bisphosphonates in adjuvant treatment of early breast cancer.
; Harbeck N; von Minckwitz G; Thürlimann B
Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S1. PubMed ID: 20427026
[No Abstract] [Full Text] [Related]
14. Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?
Coleman RE
Eur J Cancer; 2009 Jul; 45(11):1909-15. PubMed ID: 19447606
[TBL] [Abstract][Full Text] [Related]
15. Treatment for osteoporosis in people with ß-thalassaemia.
Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
[TBL] [Abstract][Full Text] [Related]
16. Denosumab an option for patients with bone metastasis from breast cancer.
Barton MK
CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096
[No Abstract] [Full Text] [Related]
17. The use of bisphosphonates in cancer treatment.
Coleman R
Ann N Y Acad Sci; 2011 Feb; 1218():3-14. PubMed ID: 20946581
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
Costa L
Breast; 2007 Dec; 16 Suppl 3():S16-20. PubMed ID: 18032044
[TBL] [Abstract][Full Text] [Related]
20. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
Enright K; Clemons M; Chow E
Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
